Entera Bio Ltd.
General ticker "ENTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $85.4M (TTM average)
Entera Bio Ltd. follows the US Stock Market performance with the rate: 27.2%.
Estimated limits based on current volatility of 5.0%: low 2.11$, high 2.33$
Factors to consider:
- Total employees count: 19 (-5.0%) as of 2023
- Top business risk factors: Ability to continue as a going concern, Capital raising, Regulatory and compliance, Labor/talent shortage/retention, Cybersecurity threats
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.29$, 3.28$]
- 2025-12-31 to 2026-12-31 estimated range: [0.96$, 2.59$]
Financial Metrics affecting the ENTX estimates:
- Positive: with PPE of -8.5 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -8.48 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Inventory ratio change, % of 0 <= 0
Short-term ENTX quotes
Long-term ENTX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.13MM | $0.00MM | $0.18MM |
| Operating Expenses | $13.20MM | $8.94MM | $9.77MM |
| Operating Income | $-13.07MM | $-8.94MM | $-9.59MM |
| Non-Operating Income | $0.13MM | $0.08MM | $0.06MM |
| R&D Expense | $5.78MM | $4.45MM | $4.50MM |
| Income(Loss) | $-12.93MM | $-8.86MM | $-9.53MM |
| Taxes | $0.14MM | $0.03MM | $0.01MM |
| Profit(Loss)* | $-13.07MM | $-8.89MM | $-9.54MM |
| Stockholders Equity | $11.75MM | $10.39MM | $8.08MM |
| Assets | $13.13MM | $11.77MM | $9.39MM |
| Operating Cash Flow | $-12.50MM | $-7.31MM | $-6.82MM |
| Capital expenditure | $0.05MM | $0.02MM | $0.00MM |
| Investing Cash Flow | $-0.10MM | $-0.02MM | $-0.00MM |
| Financing Cash Flow | $0.01MM | $6.04MM | $4.48MM |
| Earnings Per Share** | $-0.45 | $-0.31 | $-0.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.